CD4 and neoplasm: Several studies have indicated that the elevation of CD4+CD25+Foxp3+ natural regulatory T (nTreg) cells in a variety of malignancies might contribute to tumor progression by evading immune recognition and promoting an immunosuppressive environment, which were associated with poorer prognosis and reduced survival[7–12].